Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation
April 14th, 2023
This protocol demonstrates a unique mouse model of asphyxia cardiac arrest that does not require chest compression for resuscitation. This model is useful for monitoring and imaging the dynamics of brain physiology during cardiac arrest and resuscitation.
Cardiac arrest affects over half a million people in the US every year, leading to impaired neurological function primarily caused by hypoxic-ischemic brain injury. To develop better treatments, we aim to understand how cardiac arrest affects brain physiology, including microcirculatory blood flow and oxygen use, through experimental research. Advanced imaging and the monitoring methods have been established to investigate the cerebral blood flow after cardiac arrest.
However, obtaining a complete image of cerebral circulation during cardiac arrest and early resuscitation remains challenging. Our protocol involves simulating clinical asphyxia-induced cardiac arrest in mice, followed by recitation without chest compressions. This model enables the use of advanced imaging methods to study brain physiology in mice throughout the cardiac arrest process.
This model does not require complex surgical interventions, and is relatively easier to perform. More importantly, during cardiac arrest and resuscitation, animals can be kept in prone proposition with minimal animal movement, which greatly facilitates the use of various imaging modalities. The impact of cardiac arrest and its treatment strategies, such as epinephrine administration, brain hemodynamics and the neurological function, is not yet fully understood.
Our mouse model is ideal for investigating the dynamic alterations in brain circulation, vascular responses, and brain tissue oxygenation that occur during a cardiac arrest and resuscitation.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a mouse model of asphyxia cardiac arrest that facilitates the monitoring of brain physiology without the need for chest compressions. It enables advanced imaging techniques to explore cerebral dynamics during cardiac arrest and subsequent resuscitation.
Key Study Components
Area of Science
- Neuroscience
- Cardiology
- Physiology
Background
- Cardiac arrest leads to significant neurological impairment caused by hypoxic-ischemic brain injury.
- Understanding brain physiology post-cardiac arrest is crucial for developing treatments.
- Investigating cerebral blood flow dynamics remains challenging.
- Existing models often require complex interventions, hindering research progress.
Purpose of Study
- To create a simplified model for studying brain circulation during cardiac arrest.
- To assess physiological changes in the brain during resuscitation.
- To further explore impacts of treatment strategies, such as epinephrine administration.
Methods Used
- This study utilizes a mouse model to simulate clinical asphyxia-induced cardiac arrest.
- The protocol allows resuscitation without chest compressions, enabling minimal animal movement.
- Various advanced imaging modalities can be employed throughout the cardiac arrest process.
- Key experimental timelines include the stages of cardiac arrest and subsequent resuscitation.
Main Results
- The model effectively monitors the dynamic alterations in brain circulation and oxygenation.
- Insights into vascular responses and neurological function during and post-cardiac arrest were obtained.
- It highlights the significance of the proposed model for understanding brain physiology under these conditions.
Conclusions
- This study enables improved insights into the physiological changes of the brain during cardiac arrest and resuscitation.
- It does not explore multiomics analysis or metabolic measurements directly but facilitates future investigations into these areas.
- The findings enhance our understanding of neuronal responses to cardiac emergency situations.
Frequently Asked Questions
Executive Industry Relevance
Reliable preclinical models that enable real-time brain imaging during cardiac arrest and resuscitation are critical for de-risking neuroprotective strategies in biopharma R&D. This mouse asphyxia cardiac arrest model supports mechanistic interrogation of cerebral blood flow, vascular dynamics, and oxygenation, directly informing target validation and translational biomarker development. Its streamlined workflow and compatibility with advanced imaging position it as a reusable platform for early discovery and preclinical pipeline integration.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables mechanistic de-risking of neuroprotective targets by allowing direct observation of brain physiology during ischemia and reperfusion.
- Supports functional target validation through quantitative monitoring of cerebral blood flow and tissue oxygenation.
- Facilitates hypothesis-driven interrogation of vascular and neuronal responses to cardiac arrest and resuscitation.
Screening & Assay Development
- Provides a standardized, reproducible model for evaluating candidate interventions affecting brain hemodynamics post-cardiac arrest.
- Allows for quantitative imaging outputs that can be benchmarked across compounds or treatment strategies.
- Supports assay development for real-time monitoring of physiological endpoints relevant to neuroprotection.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints by modeling acute brain injury mechanisms in aged mice.
- Enables continuity from discovery through preclinical validation by supporting longitudinal imaging and physiological monitoring.
- De-risks translational advancement by providing predictive data on intervention effects in a controlled, scalable system.
Pipeline & Workflow Integration
This model bridges early discovery and preclinical validation by enabling real-time, quantitative assessment of brain physiology during cardiac arrest and resuscitation.
- Discovery Biology: Supports hypothesis testing on neurovascular mechanisms and intervention effects during ischemic injury.
- Screening: Delivers reproducible, quantitative imaging outputs for compound evaluation and assay standardization.
- Analytics: Provides high-resolution data on blood flow, vascular structure, and oxygenation for comparative analysis.
- Translational Research: Models clinically relevant injury and recovery phases, supporting biomarker alignment and risk-adjusted advancement.
- Enterprise Reuse: Offers a scalable, minimally invasive platform adaptable to diverse neuroprotective research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neuroprotective target validation and mechanistic de-risking.
- Operational Value: Streamlines imaging workflows and reduces procedural complexity for cross-team adoption.
- Strategic Value: Improves go/no-go decision quality by providing robust, quantitative physiological data.
- Portfolio Impact: Enables risk-adjusted prioritization of neuroprotective strategies and interventions.
Implementation Considerations
- Requires expertise in advanced imaging modalities and physiological monitoring in small animal models.
- Demands access to imaging infrastructure capable of real-time cerebral blood flow and oxygenation assessment.
- Benefits from standardized protocols to ensure reproducibility across research teams and studies.
- Adaptable to aged mouse cohorts, supporting translational relevance for age-associated brain injury.
- May not fully recapitulate human pathophysiology, necessitating careful interpretation of translational findings.
